All Articles

Paint and Learn

Hepatitis SA educators are offering Paint and Learn sessions where participants have fun painting on canvases as they learn and chat about viral hepatitis and blood borne viruses. This approach…

Hepatitis C & Overactive Bladder

There is a significant association between living with the hepatitis C virus and suffering from overactive bladder syndrome (OAB), according to a study published in the journal BMC Urology. The bladder has a…

In Our Library: June 2026 Highlights

Hepatitis B surveillance, adult hepatitis B vaccination, viral hepatitis and liver cancer, and more… Click on the images to access or view all resources added in the last month. Surveillance for hepatitis…

New Free Hepatitis C Telehealth Service

A new national hepatitis C telehealth service is making it easier for people to get assessed, tested and treated for hepatitis C in Australia. Launched in June by Hepatitis Australia,…

The over‑50s are most likely to overdose. Here’s how older people use drugs

Latest figures from the Pennington Institute show that older Australians make up the highest proportion of unintentional overdose deaths.

Australia’s Deadliest Year of Drug Overdoses

New data from the Penington Institute has revealed that 2,272 Australians died of drug-induced deaths in 2023, with the rate of unintentional overdoses increasing to nearly 80 per cent. On average,…

Results on New Hep B Drug: How good is it?

Pharmaceutical giant, GSK, who seem to be leading the field in developing a hepatitis B functional cure, has finally presented the results on their new drug, bepirovirsen. The 254 million…

Hep B Functional Cure – a plain language explainer

There has been a lot of talk about a functional cure for hepatitis B. What exactly does that mean? And how does that affect someone who’s living with chronic hepatitis…

4474 Lives Saved, But Targets Will Not Be Met

Powerful new data from the 2024 annual report for Measuring the progress towards the targets of the National Hepatitis B Strategy (launched by The Peter Doherty Institute at the end…

In Our Library: May 2026 Highlights

The national hepatitis strategies, Viral Hepatitis Mapping Project reports, and more… Click on the images to access, or view all resources added in the last month Sixth national hepatitis C strategy 2025…

PIEDs and Transmission Risks

The use of performance and image enhancing drugs (PIEDs) is growing. While reliable data about the number of people in the community who use them is hard to find, PIED…

Lung Cancer Screening Saves Lives

Hepatitis SA’s harm reduction peer services is encouraging clients and community members to consider lung cancer screening with the Australian government’s free lung screen program. Screening is a way of…

China Deal on Potential Hep B Cure

Pharmaceutical giant GSK has announced that it has entered into an exclusive collaboration with the Hong Kong-based pharma company Sino Biopharmaceutical to sell in mainland China, a chronic ​hepatitis B…

Bingo with a Difference

West Torrens residents can’t wait for more Hepatitis SA learning sessions after the resoundingly successful Liver Health bingo night hosted by the City of West Torrens as part of its…

Everyone, Everywhere, Right Now!

The World Hepatitis Alliance (WHA) has declared hepatitis a global health emergency. “Hepatitis is an epidemic out of control,” said WHA Chief Executive Officer, Cary James. “It is the only…

Is it Safe to Ask AI for Health Advice?

People are increasingly relying on “AI” sources for health information, but is it safe to do so? Worldwide, one in four queries to ChatGPT are health related, while almost one…

Elimination –Urgent Global Action Needed

Urgent scale-up of global action is needed if the world is to meet its target of eliminating viral hepatitis by 2030. This was the clear message from the World Health…

In Our Library: AI and Your Health

Thinking of turning to AI for health advice? Stop and think again – before putting your health information online. In Australia there are a number of high quality, credible health…

Point-of-Care Testing: The future of hep B care

A clinical trial led by the Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way…

Hepatitis B in Europe: A Persistent Problem

Chronic hepatitis B is substantially prevalent across Europe, affecting an estimated 0.7 per cent of the population in the region in 2022, according to a new study published in Eurosurveillance. While this…

baby is sitting in a crib and coughing

Child vaccination rates falling fast, with some regions barely reaching 80 per cent

By Peter Breadon, Grattan Institute and Mia Jessurun, Grattan Institute Child vaccination has been one of Australia’s biggest success stories. Before the COVID pandemic, we hit the national target of…

Systemic Failure: How Prisons Fail People who Inject Drugs and the Community

One in nine people in prisons globally have a history of injecting drug use and their risk of HIV, viral hepatitis and tuberculosis is up to 45 times higher than…

Stopping Hepatitis E

A drug that is already in clinical trials against the hepatitis C virus (HCV) has been shown to be excellent at also preventing the hepatitis E virus (HEV) from replicating.…

New Australian Hepatitis Strategies Released

Australia has taken a significant step in its commitment to ending hepatitis B and C as public health challenges, with the launch of the Fourth National Hepatitis B Strategy 2025–2030 and…